GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA en liquidation (OTCPK:ELVYY) » Definitions » EV-to-EBIT

Evolva Holding en liquidation (Evolva Holding en liquidation) EV-to-EBIT : -1.50 (As of May. 21, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Evolva Holding en liquidation EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Evolva Holding en liquidation's Enterprise Value is $154.83 Mil. Evolva Holding en liquidation's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-103.01 Mil. Therefore, Evolva Holding en liquidation's EV-to-EBIT for today is -1.50.

The historical rank and industry rank for Evolva Holding en liquidation's EV-to-EBIT or its related term are showing as below:

ELVYY' s EV-to-EBIT Range Over the Past 10 Years
Min: -19.32   Med: -3.91   Max: -0.21
Current: -0.21

During the past 13 years, the highest EV-to-EBIT of Evolva Holding en liquidation was -0.21. The lowest was -19.32. And the median was -3.91.

ELVYY's EV-to-EBIT is ranked worse than
100% of 427 companies
in the Biotechnology industry
Industry Median: 10.09 vs ELVYY: -0.21

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Evolva Holding en liquidation's Enterprise Value for the quarter that ended in Jun. 2023 was $112.35 Mil. Evolva Holding en liquidation's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-103.01 Mil. Evolva Holding en liquidation's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -91.69%.


Evolva Holding en liquidation EV-to-EBIT Historical Data

The historical data trend for Evolva Holding en liquidation's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolva Holding en liquidation EV-to-EBIT Chart

Evolva Holding en liquidation Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.88 -6.47 -5.29 -3.30 -2.38

Evolva Holding en liquidation Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -3.30 - -2.38 -

Competitive Comparison of Evolva Holding en liquidation's EV-to-EBIT

For the Biotechnology subindustry, Evolva Holding en liquidation's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolva Holding en liquidation's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolva Holding en liquidation's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Evolva Holding en liquidation's EV-to-EBIT falls into.



Evolva Holding en liquidation EV-to-EBIT Calculation

Evolva Holding en liquidation's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=154.830/-103.007
=-1.50

Evolva Holding en liquidation's current Enterprise Value is $154.83 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Evolva Holding en liquidation's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-103.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evolva Holding en liquidation  (OTCPK:ELVYY) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Evolva Holding en liquidation's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 ) =EBIT / Enterprise Value (Q: Jun. 2023 )
=-103.007/112.3485525
=-91.69 %

Evolva Holding en liquidation's Enterprise Value for the quarter that ended in Jun. 2023 was $112.35 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Evolva Holding en liquidation's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-103.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evolva Holding en liquidation EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Evolva Holding en liquidation's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Evolva Holding en liquidation (Evolva Holding en liquidation) Business Description

Traded in Other Exchanges
Address
Duggingerstrasse 23, Reinach, CHE, CH-4153
Evolva Holding SA en liquidation formerly Evolva Holding SA is a biotechnology company. The company is engaged in discovering, developing, and commercializing ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. Geographically, the company operates in Switzerland and the United States where Switzerland derives a majority of its revenue.

Evolva Holding en liquidation (Evolva Holding en liquidation) Headlines

From GuruFocus

Half Year 2023 Evolva Holding SA Earnings Call Transcript

By GuruFocus Research 02-13-2024